Package 68788-8818-3

Brand: amlodipine besylate and benazepril hydrochloride

Generic: amlodipine besylate and benazepril hydrochloride
NDC Package

Package Facts

Identity

Package NDC 68788-8818-3
Digits Only 6878888183
Product NDC 68788-8818
Description

30 CAPSULE in 1 BOTTLE (68788-8818-3)

Marketing

Marketing Status
Marketed Since 2025-01-15
Brand amlodipine besylate and benazepril hydrochloride
Generic amlodipine besylate and benazepril hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7c75fa72-9b0f-44bf-a745-dfa647ed1e78", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342"], "spl_set_id": ["7c75fa72-9b0f-44bf-a745-dfa647ed1e78"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (68788-8818-3)", "package_ndc": "68788-8818-3", "marketing_start_date": "20250115"}], "brand_name": "Amlodipine Besylate and Benazepril Hydrochloride", "product_id": "68788-8818_7c75fa72-9b0f-44bf-a745-dfa647ed1e78", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "68788-8818", "generic_name": "Amlodipine Besylate and Benazepril Hydrochloride", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine Besylate and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "ANDA078466", "marketing_category": "ANDA", "marketing_start_date": "20250115", "listing_expiration_date": "20261231"}